Reports for SANDOZ CANADA INCORPORATED
Formerly known as NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
SANDOZ CANADA INCORPORATED
Shortage reports
Actual shortage:
51 (2%)
Anticipated shortage:
9 (0%)
Avoided shortage:
19 (1%)
Resolved:
2046 (96%)
2125
Discontinuation Reports
To be discontinued:
1 (1%)
Discontinued:
98 (97%)
Reversed:
2 (2%)
101
444 (20%)
39 (64%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-12 | 220544 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2024-04-30 | 2024-05-08 | 226667 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2024-09-16 | 2024-11-19 | 237744 |
| SANDOZ CANDESARTAN | 32MG | TABLET | Resolved | 2024-12-02 | 2024-12-10 | 244434 |
| SANDOZ CANDESARTAN | 32MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79519 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79524 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79529 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79532 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2022-11-16 | 2022-11-29 | 174897 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2022-11-16 | 2022-11-29 | 174968 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2022-11-28 | 2022-12-11 | 176049 |
| SANDOZ CANDESARTAN | 32MG | TABLET | Resolved | 2022-12-28 | 2023-01-19 | 179495 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2022-12-28 | 2023-03-06 | 179502 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2023-01-27 | 2023-03-07 | 182538 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2023-01-27 | 2023-03-21 | 182541 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-27 | 2023-02-01 | 182547 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2023-01-31 | 2023-04-12 | 182805 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2023-03-27 | 2023-04-22 | 188055 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-04 | 2023-05-03 | 188640 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2023-04-11 | 2023-04-18 | 189217 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245279 |
| SANDOZ RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245282 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245285 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245288 |
| SANDOZ RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245291 |
| SANDOZ SENNA S | 50MG 8.6MG | TABLET | Discontinued | 2024-04-02 | 2024-04-03 | 224180 |
| SANDOZ SENNA S | 50MG 8.6MG | TABLET | Discontinued | 2024-05-17 | 2024-05-18 | 228268 |
| SANDOZ TOPIRAMATE TABLETS | 25MG | TABLET | Discontinued | 2022-05-24 | 2022-05-24 | 161206 |
| SANDOZ TOPIRAMATE TABLETS | 100MG | TABLET | Discontinued | 2022-05-24 | 2022-05-24 | 161211 |
| SANDOZ TOPIRAMATE TABLETS | 200MG | TABLET | Discontinued | 2022-05-24 | 2022-05-24 | 161216 |
| SANDOZ TRAMADOL | 50MG | TABLET | Discontinued | 2022-06-17 | 2022-06-18 | 163005 |
| SANDOZ ZOPICLONE | 5MG | TABLET | Discontinued | 2019-05-29 | 2019-05-29 | 85210 |
| SANDOZ-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-08-18 | 2021-08-18 | 144303 |
| SANDOZ-DICLOFENAC SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2023-08-21 | 2023-08-22 | 202590 |
| SDZ CELECOXIB | 200MG | CAPSULE | Discontinued | 2020-06-17 | 2020-06-18 | 118198 |
| SDZ CELECOXIB | 200MG | CAPSULE | Discontinued | 2020-06-22 | 2020-06-22 | 118598 |
| SODIUM AUROTHIOMALATE INJECTION BP | 50MG | SOLUTION | Discontinued | 2018-07-13 | 2018-07-13 | 55768 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |